Extension of Aβ2M amyloid fibrils with recombinant human β2-microglobulin

References

• Glenner G G, Eanes E D, Page D L. The relation of the properties of Congo red-stained amyloid fibrils to the (3-conformation. J Histochem Cytochem 1972; 20: 821–826
   PubMed Web of Science ®Google Scholar
• Glenner G G, Eanes E D, Bladen H A, Linke R P, Termine J D. (3-Pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974; 22: 1141–1158
   PubMed Web of Science ®Google Scholar
• Sipe J D. Amyloidosis. Crit Rev Clin Lab Sci 1994; 31: 325–354
   PubMed Web of Science ®Google Scholar
• Benson M D. Amyloidosis. The Metabolic and Molecular Bases of Inherited Disease, C R Scriver, A L Beaudet, W S Sly, D Valle, 1995; Vol.1: 4159–4191
   Google Scholar
• Cohen A S, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 1959; 183: 1202–1203
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen A S. High resolution electron microscopic analysis of the amyloid fibril. J Cell Biol 1967; 33: 679–706
   PubMed Web of Science ®Google Scholar
• Snow A D, Willmer J, Kisilevsky R. Sulfated gly-cosaminoglycans: A common constituent of all amyloids. Lab invest 1987; 56: 120–123
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992; 135: 235–238
   PubMed Web of Science ®Google Scholar
• Pepys M B, Booth D R, Hutchinson W L, Gallimore J R, Collins P M, Hohenester E. Amyloid P component. A critical review. Amyloid: Int J Exp Clin Invest 1997; 4: 274–295
   Web of Science ®Google Scholar
• Picken M M, Larrondo-Lillo M, Coria F, Gallo G, Shelanski M L, Frangione B. Distribution of the protease inhibitor al-antichymotrypsin in cerebral and systemic amyloid. J Neuropath Exp Neurol 1990; 49: 41–48
   PubMed Web of Science ®Google Scholar
• Koch K M. Dialysis-related amyloidosis. Kidney Int 1992; 41: 1416–1429
   PubMed Web of Science ®Google Scholar
• Charra B, Calemard E, Uzam M, Terat J C, Vanel T, Laurent G. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term hemodialysis patients. Proc Eur Dial Transplant Assoc 1984; 21: 291–295
   Google Scholar
• Gejyo F, Arakawa M. Dialysis amyloidosis: Current disease concepts and new perspectives for its treatment. Contrib Nephrol 1990; 78: 47–60
   PubMedGoogle Scholar
• Gejyo F, Homma N, Arakawa M. Carpal tunnel syndrome and beta-2 microglobulin amyloidosis: Histological and biochemical aspects. Dialysis Amyloidosis, F Gejyo, D Brancaccio, T Bardin. Wichtig Editore, Milano 1989; 35–56
   Google Scholar
• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A S, Schmid K. A new form of amyloid protein associated with hemodialysis was identified as P2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–706
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Munoz P C, Casey T T, DiRaimondo C R, Stone W J, Prelli F C, Rodrigues M M, Poulik M D, Frangione B. Polymerization of intact β2Microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 1986; 83: 7908–7912
   PubMed Web of Science ®Google Scholar
• Campistol J M, Solé M, Bombi J A, Rodriguez R, Mirapeix E, Muñoz-Gomez J, Revert O W. In vitro spontaneous synthesis of P2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Pathol 1992; 141: 241–247
   PubMed Web of Science ®Google Scholar
• Campistol J M, Bernard D, Papastoitsis G, Solé M, Kasirsky J, Skinner M. Polymerization of normal and intact bT2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. Kidney Int 1996; 50: 1262–1267
   PubMed Web of Science ®Google Scholar
• Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989; 298: 867–868
   PubMed Web of Science ®Google Scholar
• van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012–1019, and the Working Party on Dialysis Amyloidosis
   PubMed Web of Science ®Google Scholar
• Davision A M. β2-microglobulin and amyloidosis: Who is at risk?. Nephrol Dial Transplant 1995; 10(Supple 10)48–51
   Google Scholar
• Naiki H, Higuchi K, Nakakuki K, Takeda T. Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest 1991; 65: 104–110
   PubMed Web of Science ®Google Scholar
• Jarrett J T, Lansbury P T, Jr. Seeding “one-dimen-siona! crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie. Cell 1993; 73: 1055–1058
   PubMed Web of Science ®Google Scholar
• Naiki H, Nakakuki K. First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro. Lab Invest 1996; 74: 374–383
   PubMed Web of Science ®Google Scholar
• Naiki H, Gejyo F, Nakakuki K. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 1997; 36: 6243–6250
   PubMed Web of Science ®Google Scholar
• Naiki H, Hashimoto N, Suzuki S, Kimura H, Nakakuki K, Gejyo F. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid: Int J Exp Clin Invest 1997; 4: 223–232
   Web of Science ®Google Scholar
• Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C. Implication of increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170–1181
   PubMed Web of Science ®Google Scholar
• Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T. β2Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243–1252
   PubMed Web of Science ®Google Scholar
• Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier V M. Identification of pentosidine as a native structure for advanced glycation end products in p2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 1996; 93: 2353–2358
   PubMed Web of Science ®Google Scholar
• Niwa T, Sato M, Katsuzaki T, Tomoo T, Miyazaki T, Takemichi N, Takei Y, Kondo T. Amyloid β2-microglobulin is modified with Ne-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 1996; 50: 1303–1309
   PubMed Web of Science ®Google Scholar
• Hashimoto N, Naiki H, Gejyo F. Modification of β2Microglobulin with D-glucose or 3-deoxyglucosone inhibits dialysis-related amyloid fibril extension in vitro. Amyloid: Int J Exp Clin Invest 1999; 6: 256–264
   PubMed Web of Science ®Google Scholar
• Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A, Cohen A S, Schmid K. Glycosaminogly-cans of the hemodialysis-associated carpal tunnel synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin Chem 1990; 36: 88–91
   PubMed Web of Science ®Google Scholar
• Yamada T, Kakihara T, Gejyo F, Okada M. A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits. Ann Clin Lab Sci 1994; 24: 243–249
   PubMed Web of Science ®Google Scholar
• Campistol J M, Shirahama T, Abraham C R, Rodgers O G, Sote M, Cohen A S, Skinner M. Demonstration of plasma proteinase inhibitors in β2-microglobulin amyloid deposits. Kidney Int 1992; 42: 915–923
   PubMed Web of Science ®Google Scholar
• Garcìarcía-Aa M, Gouin-Charnet A, Mourad G, Argilés A. Monomeric and dimeric β2-microglobulin may be extracted from amyloid deposits in vitro. Nephrol Dial Transplant 1997; 12: 1192–1198
   PubMed Web of Science ®Google Scholar
• Gejyo F, Kazama J J, Hasegawa S, Honma N, Nishi S, Arakawa M, Odano I. 131I-β2-microglobulin scintigraphy in patients with dialysis amyloidosis. Clin Nephrol 1995; 44: S14–S18
   PubMed Web of Science ®Google Scholar
• Suggs S V, Wallace R V, Hirose T, Kawashima E H, Itakura K. Use of synthetic oligonucleotides as hybridization probes: Isolation of cloned cDNA sequences for human β2-microglobulin. Proc Natl Acad Sci USA 1981; 78: 6613–6617
   PubMed Web of Science ®Google Scholar
• Kihira Y, Mori K, Miyazaki K, Matuo Y. Production of recombinant human matrix metalloproteinase 7 (matrilysin) with potential role in tumor invasion by refolding from Escherichia coli, inclusion bodies and development of sandwich ELISA of MMP-7. Urol Oncol 1996; 2: 20–26
   PubMedGoogle Scholar
• Uchida K, Kondoh K, Matuo Y. Recombinant M, B- and MB-type isozymes of human phosphoglyceric acid mutase: their large-scale production and preparation of polyclonal antibodies specific to M- and B-type isozymes. Clin Chim Acta 1995; 237: 43–58
   PubMed Web of Science ®Google Scholar
• Beers E P, Callis J. Utility of polyhistidine-tagged ubiquitin in the purification of ubiquitin-protein conjugates and as an affinity ligand for the purification of ubiquitin-specific hydrolases. J Biol Chem 1993; 268: 21645–21649
   PubMed Web of Science ®Google Scholar
• Garboczi D N, Hung D T, Wiley D C. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli, and complexed with single antigenic peptides. Proc Natl Acad Sci USA 1992; 89: 3429–3433
   PubMed Web of Science ®Google Scholar
• Pras M, Zucker-Franklin D, Rimon A, Franklin E C. Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. J Exp Med 1969; 130: 777–791
   PubMed Web of Science ®Google Scholar
• Shägger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166: 368–379
   PubMed Web of Science ®Google Scholar
• Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Okon M, Bray P, Vucelic D. 1H NMR assignments and secondary structure of human β2-microglobulin in solution. Biochemistry 1992; 31: 8906–8915
   PubMed Web of Science ®Google Scholar
• Connors L H, Shirahama T, Skinner M, Fenves A, Cohen A S. In vitro formation of amyloid fibrils from intact β2microglobulin. Biochem Biophys Res Commun 1985; 131: 1063–1068
   PubMed Web of Science ®Google Scholar